Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
332 Leser
Artikel bewerten:
(1)

Angel Yeast Invests in New Enzyme Project Capable of 5,000 Tons Annual Production Output

YICHANG, China, Dec. 22, 2021 /PRNewswire/ -- Angel Enzyme Preparation (Yichang) Co., Ltd., ("Angel Enzyme Preparation"), a wholly-owned subsidiary of Angel Yeast Co., Ltd., is well underway with construction on its new green manufacturing project in Angel Biotechnology Industrial Park, Xiaoting District, Yichang City, which commenced in September 2021. Once complete, the project will have an annual enzyme production output of 5,000 tons and will significantly enhance the company's competitive advantage in the enzyme preparations and biotechnology industry.

Angel Enzyme Preparation (Yichang) Co., Ltd., is well underway with construction on its enzyme manufacturing project, which commenced in September.

Angel Enzyme Preparation's new green manufacturing project will cover 80 hectares and has a planned total investment of RMB 340 million. The project will use advanced global manufacturing technology to establish a sustainable and intelligent manufacturing base for new enzyme preparations, and is estimated to be completed by Q4 2022. After being put into production, it is expected the project will generate RMB 350 million in annual revenue - including RMB 130 million in profits - and create 200 jobs.

"Angel Yeast's green manufacturing project marks a significant milestone for the company. With this project, we will be able to meet the production capacity requirements of Angel Yeast's enzyme preparations business in the future, while also continuing to enhance our sustainability efforts. Using green and intelligent manufacturing processes, this project accelerates the pace of Angel Yeast's development as we strive to become a global professional biotech company," said Zhihong Du, General Manager of Angel Enzyme Preparation and the leader of the project.

Angel Enzyme Preparation was established in 2021 as a wholly-owned subsidiary of Angel Yeast and is registered in Yichang, Hubei Province. The company was originally founded in 2011 and served as a Special Enzyme Preparation Business Department within Angel Yeast before becoming a subsidiary. And in 2012, Angel Yeast established its Special Enzyme Preparation Base.

Angel Enzyme Preparation is committed to becoming a strategic sustainable development partner that offers world-leading solutions and comprehensive biotechnology applications. By harnessing Angel Yeast's cutting-edge facilities and the flexibility of biological manufacturing, Angel Enzyme Preparation will engage in the R&D, production, and application of enzyme preparations and various biological products. In addition, the company will be a one-stop service for CDMOs seeking technology development, processing and production services; as well as customers wanting project incubation for custom products.

As a professional production team, Angel Enzyme Preparation guarantees high-quality and stable enzyme preparations such as nuclease, deaminase, glutaminase, lactase, and protease, which are widely used in baking, alcohol, proteolysis, nucleic acid hydrolysis, dairy product processing, and feed industries. All Angel Enzyme Preparation products share five key characteristics: high conversion efficiency, strong specificity, reliable quality, strong tolerance, and eco-friendly production. Angel Enzyme Preparation also owns ANNZYMES, an independent brand of special enzyme preparations.

Looking ahead, Angel Yeast will focus on diversifying its production capabilities with a focus on yeast, health food ingredients, nutritious health foods, and the development of new biological technologies. In doing so, the company will realize its vision of becoming an "internationalized and specialized biotechnology company".

About Angel Yeast

Founded in 1986, Angel Yeast Co., Ltd specializes in the production of yeast and yeast derivatives. Its product range includes baker's yeast and ingredients, Chinese dim sum and seasoning, savory yeast extract, human health, animal nutrition, plant nutrition, distilled spirits and biofuels, microbial nutrition, and enzymes.

Photo - https://mma.prnewswire.com/media/1715085/1.jpg
Logo - https://mma.prnewswire.com/media/1586948/angel_logo_Logo.jpg

© 2021 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.